« Previous article
Latest Microbiology ...

6th March 2020  Content supplied by: rapidmicrobiology.com

Latest Microbiology Newsletter - 3 March 2020


This week was again dominated by COVID-19 and SARS-CoV-2 - remember SARS-CoV-2 is the name of the virus and COVID-19 is the name of the disease it causes. SARS-CoV-2 stands for Severe Acute Respiratory Syndrome Corona Virus 2 and COVID-19 stands for Coronavirus Disease 2019. The European IAFP meeting has been cancelled and ECCMID is mostly probably not going ahead - we're waiting on confirmation on that one. Then the other big news for the industry was Thermo Fisher are buying Qiagen, this will take Thermo from being a large to a huge player in the PCR market.

This rapidmicrobiology newsletter introduces our SARS-CoV-2 special test method guide to kit, swabs and quality control materials - read it here Testing for the Wuhan Coronavirus - COVID-19 - SARS-CoV-2

  • COPAN have reponded to the high demand for viral swabs with transport media by increased production

  • We have a special interview with Gary Keating (HiberGene's CTO), HiberGene have a LAMP-based COVID-19 assay is currently primed for evaluation in China for clinical use. The 'near-patient' assay can provide results in one hour after taking a sample from the patient.

  • Testing for allergens in cooked eggs is specially challenging, the R-Biopharm have a new ELISA test Ridascreen® Egg that quantifies the allergic egg proteins ovomucoid and ovalbumin both in native and in processed form.

  • Reduce time and input in preparing enrichment media with Actero™ EZ-Media Bag, the medium is ready-to-use in 30 minutes or less.

 

To read these updates and more in the rapidmicrobiology newsletter go to: www.rapidmicrobiology.com/view-newsletter/196

signupmainsitebanner


    

Tags:

Date Published: 6th March 2020

Source article link: https://www.rapidmicrobiology.com/view-newsletter/196/


View full company details